Page 7 - 2021_05-Haematologica-web

1443 Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells Hiba El Hajj et al.
https://doi.org/10.3324/haematol.2020.264523
Letters to the Editor
1457 Immunologic characterization of COVID-19 patients with hematological cancer Catarina Maia et al.
https://doi.org/10.3324/haematol.2020.269878
1460 The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia Yun Zhou et al.
https://doi.org/10.3324/haematol.2020.246918
1466 Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma Keren Isaev et al.
https://doi.org/10.3324/haematol.2020.255950
1472 Hemostatic alterations in COVID-19 Flora Peyvandi et al.
https://doi.org/10.3324/haematol.2020.262634
1476 How to implement endurance exercise training in sickle cell disease Laurent A. Messonnier et al.
https://doi.org/10.3324/haematol.2020.267047
1480 Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study
Valentina Gambacorta et al.
https://doi.org/10.3324/haematol.2019.238543
1484 Exosome-driven lipolysis and bone marrow niche remodeling support leukemia expansion Bijender Kumar et al.
https://doi.org/10.3324/haematol.2019.246058
1489 Very low incidence of Clostridioides difficile infection in pediatric sickle cell disease patients Philip Lee et al.
https://doi.org/10.3324/haematol.2019.244582
1491 Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia Hui Wei et al.
https://doi.org/10.3324/haematol.2020.267526
1496 Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network
Davine Hofste op Bruinink et al.
https://doi.org/10.3324/haematol.2020.267831
1500 Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab
Nadia Peragine et al.
https://doi.org/10.3324/haematol.2020.262071
Case Reports
1504 Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy Ranjit Nair et al.
https://doi.org/10.3324/haematol.2020.259952
1507 Unusual survival of a twin with homozygous α0-thalassemia due to chimerism Dejian Pang et al.
https://doi.org/10.3324/haematol.2020.262600
haematologica Journal of the Ferrata Storti Foundation
T-Cell Leukemia
Haematologica 2021; vol. 106 no. 5 - May 2021 http://www.haematologica.org/